A cost-effectiveness analysis of the use of a mechanical barrier system to reduce the risk of mistransfusion

Transfusion
J P AuBuchon, B Littenberg

Abstract

A blood component is transfused to a patient other than the intended recipient because of patient and sample identification problems once in about every 24,000 transfusions. An investigation was performed of the cost-effectiveness of a barrier system to prevent mistransfusion of a unit of red cells through this kind of error. A decision analysis model was constructed that took into account nonfatal and fatal events, costs of patient care, and legal costs. The model was used to determine the cost-effectiveness of the barrier system in terms of cost per year of life saved and lives saved per million transfusions. The barrier system is predicted to save 1.5 lives per million transfusions when used as intended. If the cost-effectiveness calculations are based on an average damage award for a fatality of more than $725,000 and a chance of mistransfusion exceeding 1 in 16,700, use of the system results in reduced healthcare expenditures. If no legal costs are included in the cost-effectiveness calculations, use of the system costs $197,000 per year of life saved. Routine use of the system extends patient life by 1 year per 60,000 units transfused. The application of a barrier system to prevent mistransfusion and related morbidity and...Continue Reading

Citations

Jul 26, 2003·Transfusion Medicine Reviews·Walter H DzikRosyln Yomtovian
Feb 7, 2001·Gastroenterology Clinics of North America·G S MaltzJ L Carson
Feb 11, 1999·The New England Journal of Medicine·L T GoodnoughJ P AuBuchon
Oct 31, 2000·Current Opinion in Hematology·M Marconi, G Sirchia
Oct 31, 2000·Current Opinion in Hematology·A Pereira
Oct 18, 2001·Current Opinion in Hematology·I A ShulmanL M Maffei
Jan 26, 2005·Current Opinion in Hematology·M F Murphy, J D S Kay
Jan 1, 2012·Journal of Blood Transfusion·Jay P Brooks
Feb 20, 2009·Anesthesia and Analgesia·Jeanne E Hendrickson, Christopher D Hillyer
Jun 29, 2010·Clinical Chemistry and Laboratory Medicine : CCLM·Massimo Franchini
Dec 22, 2009·Biologicals : Journal of the International Association of Biological Standardization·Marinus van HulstMaarten J Postma
Feb 27, 2009·Biologicals : Journal of the International Association of Biological Standardization·Michael BuschBrian McDonough
Dec 6, 2008·Transfusion Medicine Reviews·Brian Custer, Jeffrey S Hoch
Aug 2, 2006·American Journal of Clinical Pathology·Priscila I FigueroaLoni Calhoun
Jul 18, 2007·Seminars in Diagnostic Pathology·Anand S DigheKent B Lewandrowski
Jul 27, 2007·Best Practice & Research. Clinical Anaesthesiology·Aryeh ShanderDonat R Spahn
Jun 24, 2004·Vox Sanguinis·M F Murphy, J D S Kay
Aug 16, 2006·Vox Sanguinis·P Pagliaro, P Rebulla
Jan 26, 1999·Clinical Orthopaedics and Related Research·J L Carson, A Y Chen
Jul 27, 1999·Archives of Pathology & Laboratory Medicine·J P AuBuchon
Aug 2, 2006·Archives of Pathology & Laboratory Medicine·Karen Quillen, Kate Murphy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.